146 related articles for article (PubMed ID: 9224645)
1. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.
Obrador E; Navarro J; Mompo J; Asensi M; Pellicer JA; Estrela JM
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):183-9. PubMed ID: 9224645
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tumour cell sensitivity to TNF-induced oxidative stress and cytotoxicity: role of glutathione.
Obrador E; Navarro J; Mompo J; Asensi M; Pellicer JA; Estrela JM
Biofactors; 1998; 8(1-2):23-6. PubMed ID: 9699004
[TBL] [Abstract][Full Text] [Related]
3. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; Viña J; Estrela JM
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms for tumour cell sensitivity to TNF-alpha and potential therapeutic applications.
Obrador E; Carretero J; Pellicer JA; Estrela JM
Curr Pharm Biotechnol; 2001 Jun; 2(2):119-30. PubMed ID: 11480417
[TBL] [Abstract][Full Text] [Related]
5. Human tumour necrosis factor-alpha inhibits glucose transport in cultured Ehrlich ascites tumour cells.
Fung KP; Lam WP; Choy YM; Lee CY
Life Sci; 1995; 57(1):PL1-6. PubMed ID: 7541099
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
Terlikowski S; Nowak HF
Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP.
Lasso de la Vega MC; Terradez P; Obrador E; Navarro J; Pellicer JA; Estrela JM
Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):99-105. PubMed ID: 8129737
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glutathione metabolism in Ehrlich ascites tumour cells.
Estrela JM; Hernandez R; Terradez P; Asensi M; Puertes IR; Viña J
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):257-62. PubMed ID: 1520278
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action.
Zimmerman RJ; Marafino BJ; Chan A; Landre P; Winkelhake JL
J Immunol; 1989 Feb; 142(4):1405-9. PubMed ID: 2915120
[TBL] [Abstract][Full Text] [Related]
10. Glutamine potentiates TNF-alpha-induced tumor cytotoxicity.
Obrador E; Carretero J; Esteve JM; Pellicer JA; Pascual A; Petschen I; Estrela JM
Free Radic Biol Med; 2001 Sep; 31(5):642-50. PubMed ID: 11522449
[TBL] [Abstract][Full Text] [Related]
11. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
Terlikowski S; Sulkowska M; Nowak HF
J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial glutathione depletion by glutamine in growing tumor cells.
Carretero J; Obrador E; Pellicer JA; Pascual A; Estrela JM
Free Radic Biol Med; 2000 Nov; 29(9):913-23. PubMed ID: 11063916
[TBL] [Abstract][Full Text] [Related]
13. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
Zimmerman RJ; Chan A; Leadon SA
Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
[TBL] [Abstract][Full Text] [Related]
14. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
Hauser GJ; McIntosh JK; Travis WD; Rosenberg SA
Cancer Res; 1990 Jun; 50(12):3503-8. PubMed ID: 2340500
[TBL] [Abstract][Full Text] [Related]
16. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays.
Estrela JM; Obrador E; Navarro J; Lasso De la Vega MC; Pellicer JA
Nat Med; 1995 Jan; 1(1):84-8. PubMed ID: 7584960
[TBL] [Abstract][Full Text] [Related]
17. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo.
Navarro J; Obrador E; Carretero J; Petschen I; Aviñó J; Perez P; Estrela JM
Free Radic Biol Med; 1999 Feb; 26(3-4):410-8. PubMed ID: 9895233
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cytotoxicity and suppression of glucose transport rate by combined treatment of recombinant human tumour necrosis factor-alpha and hyperthermia on L929 cells.
Liong E; Kong SK; Au KK; Li JY; Xu GY; Lee YL; Kwok TT; Choy YM; Lee CY; Fung KP
Life Sci; 1999; 65(8):PL81-6. PubMed ID: 10466752
[TBL] [Abstract][Full Text] [Related]
19. Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells.
Hashimoto S; Gon Y; Matsumoto K; Takeshita I; MacHino T; Horie T
Clin Exp Allergy; 2001 Jan; 31(1):144-51. PubMed ID: 11167962
[TBL] [Abstract][Full Text] [Related]
20. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells.
Noda T; Iwakiri R; Fujimoto K; Aw TY
FASEB J; 2001 Oct; 15(12):2131-9. PubMed ID: 11641239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
